Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or Itraconazole
NCT05631678
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced or Metastatic NSCLC
Interventions
DRUG:
Rifampicin; ASK120067
DRUG:
ASK120067;itraconazole
Sponsor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.